Differential Expression of Neuroleukin in Osseous Tissues and Its Involvement in Mineralization During Osteoblast Differentiation
Open Access
- 1 November 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 16 (11), 1994-2004
- https://doi.org/10.1359/jbmr.2001.16.11.1994
Abstract
Osteoblast differentiation is a multistep process that involves critical spatial and temporal regulation of cellular processes marked by the presence of a large number of differentially expressed molecules. To identify key functional molecules, we used differential messenger RNA (mRNA) display and compared RNA populations isolated from the defined transition phases (proliferation, matrix formation, and mineralization) of the MC3T3‐E1 osteoblast‐like cell line. Using this approach, a complementary DNA (cDNA) fragment was isolated and identified as neuroleukin (NLK), a multifunctional cytokine also known as autocrine motility factor (AMF), phosphoglucose isomerase (PGI; phosphohexose isomerase [PHI]), and maturation factor (MF). Northern analysis showed NLK temporal expression during MC3T3‐E1 cell differentiation with a 3.5‐fold increase during matrix formation and mineralization. Immunocytochemical studies revealed the presence of NLK in MC3T3‐E1 cells as well as in the surrounding matrix, consistent with a secreted molecule. In contrast, the NLK receptor protein was detected primarily on the cell membrane. In subsequent studies, a high level of NLK expression was identified in osteoblasts and superficial articular chondrocytes in bone of 1‐, 4‐, and 8‐month‐old normal mice, as well as in fibroblasts, proliferating chondrocytes, and osteoblasts within a fracture callus. However, NLK was not evident in hypertrophic chondrocytes or osteocytes. In addition, treatment of MC3T3 cells with 6‐phosphogluconic acid (6PGA; a NLK inhibitor) resulted in diminishing alkaline phosphatase (ALP) activity and mineralization in MC3T3‐E1 cells, especially during the matrix formation stage of differentiating cells. Taken together, these data show specific expression of NLK in discrete populations of bone and cartilage cells and suggest a possible role for this secreted protein in bone development and regeneration.Keywords
This publication has 27 references indexed in Scilit:
- Temporal Expression of the Chondrogenic and Angiogenic Growth Factor CYR61 During Fracture RepairJournal of Bone and Mineral Research, 2000
- Cloning of a Novel cDNA Expressed during the Early Stages of Fracture HealingBiochemical and Biophysical Research Communications, 1998
- Autocrine motility factor receptor is a marker for a distinct membranous tubular organelle.The Journal of cell biology, 1995
- Gene expression during osteogenic differentiation in mandibular condyles in vitro.The Journal of cell biology, 1990
- The Diagnostic Validity of the Serum Tumor Marker Phosphohexose Isomerase (PHI) in Patients with Gastrointestinal, Kidney, and Breast CancerCancer Investigation, 1990
- Development and regional expression of chicken neuroleukin (glucose‐6‐phosphate isomerase) messenger RNAJournal of Neuroscience Research, 1989
- Molecular Cloning and Expression of Neuroleukin, a Neurotrophic Factor for Spinal and Sensory NeuronsScience, 1986
- Neuroleukin: A Lymphokine Product of Lectin-Stimulated T CellsScience, 1986
- Effect of 1,25-dihydroxyvitamin D3 on alkaline phosphatase activity and collagen synthesis in osteoblastic cells, clone MC3T3-El1Biochemical and Biophysical Research Communications, 1984
- In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria.The Journal of cell biology, 1983